Taipei, Feb. 26 (CNA) A research team at Taiwan’s National Yang Ming Chiao Tung University (NYCU) has transferred the technology for its experimental stem cell therapy treatment for pulmonary fibrosis to two biotech companies, in a first step toward beginning clinical trials, it announced Friday.



Source link

LEAVE A REPLY